Authored By: Sarah
10 Aug 2023

Oligonucleotide Synthesis Market to exhibit growth at a CAGR of 13.47% and USD 2870.69 mn revenue growth 

 Key Drivers and Market Trends

The advent of technological innovations in oligonucleotide synthesis and the surging research activities in the pharmaceutical and biotechnology sectors has boosted the market advancement of the oligonucleotide synthesis market globally. The oligonucleotide synthesis market across the globe is predicted to witness market growth of USD 2,870.69 million through 2022 and 2027. It is forecasted the market will exhibit growth at a CAGR of 13.47%.

Navigating through the market drivers of oligonucleotide synthesis: When it comes to the growth drivers it includes factors like 

  • The prevalence of chronic and life-threatening diseases is propelling the demand for pharmaceutical and biotechnological research on the development of effective therapeutics and diagnostic techniques.
  • Advancements in life sciences research have resulted in an improved understanding of biological systems which has propelled the increase in life science research using genetic engineering technologies.

oligonucleotide synthesis market, global oligonucleotide synthesis market, oligonucleotide synthesis market report, oligonucleotide synthesis market share

"Technavio's research report lists all the growth drivers that are likely to boost market growth along with a detailed analysis of the market segments, trends, and challenges that are likely to impact market growth."

Market Trends: As per the current market trends rise in demand for cost-effective and high-throughput oligonucleotide synthesis is a primary trend in the oligonucleotide synthesis market. Production of large-scale desired gene sequences at cost-effective prices will enable rapid progress in both fundamental and applied biological research. 

Oligonucleotide Synthesis Market: Segments and Geographical Regions

  • This report segments the market Application (PCR primers, Fluorescence in situ hybridization, PCR assays, and panels, DNA microarrays, and Others), End-user (Pharmaceutical and biotechnology companies, Research and academic institutes, Diagnostic laboratories, and Hospitals), and Geography (North America, Europe, Asia, and Rest of World (ROW)).  
  • 43% of the market growth will originate from North America during the forecast period. 
  • This research report will provide insights into the current market share of each segment along with growth projections for the next five years.  An understanding of the key drivers will enable clients to leverage growth opportunities to their advantage with a view to short-term and long-term business goals. 

Key Companies: Major market players in this segment comprise names like Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biocon Ltd., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., etc. Our report includes qualitative and quantitative analyses of vendors with a wider understanding of the business ecosystem. Download a Sample Report

Read News Read Less
Interested in this report?
Get your sample now!